We described that CTLA-4 might regulate tumor immune microenvironment by enhancing relevant immunomodulators, such as IL-15 and CSF-1, which prime NK and M1 macrophages, two cells interconnected by their immunomodulatory functions. This evidence concerns the gene CTLA4 and neoplasm.